JPH06509082A - バッカチン3および10−デアセチルバッカチン3の誘導体類の製造方法 - Google Patents
バッカチン3および10−デアセチルバッカチン3の誘導体類の製造方法Info
- Publication number
- JPH06509082A JPH06509082A JP5502037A JP50203793A JPH06509082A JP H06509082 A JPH06509082 A JP H06509082A JP 5502037 A JP5502037 A JP 5502037A JP 50203793 A JP50203793 A JP 50203793A JP H06509082 A JPH06509082 A JP H06509082A
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- acid
- producing
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 title claims 4
- 229930190007 Baccatin Natural products 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 125000006239 protecting group Chemical group 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 13
- -1 1-ethoxyethyl Chemical group 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims description 7
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 229930014667 baccatin III Natural products 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical class [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical class C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 claims 1
- 150000004678 hydrides Chemical group 0.000 claims 1
- 239000000047 product Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000004665 trialkylsilyl group Chemical group 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RZARFIRJROUVLM-GVHYBUMESA-N (3r)-3-amino-2-hydroxy-3-phenylpropanoic acid Chemical class OC(=O)C(O)[C@H](N)C1=CC=CC=C1 RZARFIRJROUVLM-GVHYBUMESA-N 0.000 description 1
- WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical compound COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- YWLXLRUDGLRYDR-LUPIKGFISA-N 7-epi-10-deacetylbaccatin iii Chemical group O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-LUPIKGFISA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000719 anti-leukaemic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 150000004200 baccatin III derivatives Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (6)
- 1.一般式: ▲数式、化学式、表等があります▼(VI)[式中、 R1はアセチル基またはエーテル、エステルもしくはカーボネートの形状のヒド ロキシル官能基の保護基を表し、そしてG1はエーテル、エステルまたはカーボ ネートの形状のヒドロキシル官能基の保護基を表し、そして R2はメトキシメチル、1−エトキシエチル、ベンジルオキシメチル、(β−ト リメチルシリルエトキシ)メチルまたはテトラヒドロピラニル基から選択される ヒドロキシル官能基の保護基を表す]のタキサン誘導体を酸媒体中で処理するこ とを特徴とする、一般式:▲数式、化学式、表等があります▼(I)[式中、 Rはターシャリーーブトキシまたはフェニル基を表し、R1およびG1は以上で 定義されている如くである]の、2′R、3′Sまたは2′S,3′S形の、バ ッカチンIIIおよび10−デアセチルバッカチンIIIの誘導体類の製造方法 。
- 2.Rがターシャリーーブトキシまたはフェニル基を表し、そしてR1がアセチ ルまたは2,2,2−トリクロロエトキシカルボニル基を表し、そしてG1が2 ,2,2−トリクロロエトキシカルボニル基を表す、2′R,3′Sまたは2′ S,3′S形の、一般式(I)のバッカチンIIIまたは10−デアセチルバッ カチンIIIの誘導体を製造するための、請求の範囲第1項に記載の方法。
- 3.酸媒体中での処理を強無機酸のアルコール溶液を用いて行うことを特徴とす る、請求の範囲第1項に記載の方法。
- 4.塩酸のエタノール溶液を使用することを特徴とする、請求の範囲第1項に記 載の方法。
- 5.任意にクロマトグラフィーまたは結晶化により精製されていてもよい請求の 範囲第1〜3項のいずれかの方法により得られるタキサン誘導体を既知方法によ り処理して保護基を除去することを特徴とする、一般式: ▲数式、化学式、表等があります▼ [式中、 Rはターシャリー−ブトキシまたはフェニル基を表し、そしてR′1は水素原子 またはアセチル基を表す]のタキサン誘導体を製造するための、請求の範囲第1 〜4項のいずれかの方法により得られるタキサン誘導体の使用。
- 6.任意にクロマトグラフィーまたは結晶化により精製されていてもよい請求の 範囲第2項に記載の方法により得られるタキサン誘導体をアルコール媒体中で2 0℃〜反応混合物の還流温度の間の温度において酢酸中の亜鉛で処理しそして得 られた生成物を単離することを特徴とする、請求の範囲第5項で定義されている 如きタキサン誘導体を製造するための請求の範囲第2項の方法により得られるタ キサン誘導体の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9108673A FR2678930B1 (fr) | 1991-07-10 | 1991-07-10 | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii. |
FR91/08673 | 1991-07-10 | ||
PCT/FR1992/000649 WO1993001179A1 (fr) | 1991-07-10 | 1992-07-08 | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06509082A true JPH06509082A (ja) | 1994-10-13 |
JP3085710B2 JP3085710B2 (ja) | 2000-09-11 |
Family
ID=9414931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP05502037A Expired - Lifetime JP3085710B2 (ja) | 1991-07-10 | 1992-07-08 | バッカチン▲iii▼および10−デアセチルバッカチン▲iii▼の誘導体類の製造方法 |
Country Status (25)
Country | Link |
---|---|
US (1) | US5578739A (ja) |
EP (2) | EP0593641B1 (ja) |
JP (1) | JP3085710B2 (ja) |
KR (1) | KR100206458B1 (ja) |
AT (1) | ATE132145T1 (ja) |
AU (1) | AU662346B2 (ja) |
CA (1) | CA2111319C (ja) |
CZ (1) | CZ281288B6 (ja) |
DE (1) | DE69207194T2 (ja) |
DK (1) | DK0593641T3 (ja) |
ES (1) | ES2081120T3 (ja) |
FI (1) | FI109792B (ja) |
FR (1) | FR2678930B1 (ja) |
GR (1) | GR3018543T3 (ja) |
HU (1) | HU217115B (ja) |
IE (1) | IE73637B1 (ja) |
MX (1) | MX9204029A (ja) |
NO (2) | NO302521B1 (ja) |
NZ (1) | NZ243491A (ja) |
PL (1) | PL169780B1 (ja) |
RU (1) | RU2088578C1 (ja) |
SK (1) | SK281560B6 (ja) |
WO (1) | WO1993001179A1 (ja) |
YU (1) | YU49175B (ja) |
ZA (1) | ZA925098B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003201287A (ja) * | 1993-03-22 | 2003-07-18 | Aventis Pharma Sa | タキソテレ三水和物 |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6794523B2 (en) | 1991-09-23 | 2004-09-21 | Florida State University | Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them |
US5272171A (en) * | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
US5294637A (en) * | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
US5380751A (en) * | 1992-12-04 | 1995-01-10 | Bristol-Myers Squibb Company | 6,7-modified paclitaxels |
MX9308012A (es) * | 1992-12-24 | 1994-08-31 | Bristol Myers Squibb Co | Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen. |
US5646176A (en) * | 1992-12-24 | 1997-07-08 | Bristol-Myers Squibb Company | Phosphonooxymethyl ethers of taxane derivatives |
CA2129288C (en) * | 1993-08-17 | 2000-05-16 | Jerzy Golik | Phosphonooxymethyl esters of taxane derivatives |
FR2718135B1 (fr) * | 1994-04-05 | 1996-04-26 | Rhone Poulenc Rorer Sa | Procédé de préparation d'hydroxy-7 taxanes. |
US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
US6107332A (en) | 1995-09-12 | 2000-08-22 | The Liposome Company, Inc. | Hydrolysis-promoting hydrophobic taxane derivatives |
US6051600A (en) * | 1995-09-12 | 2000-04-18 | Mayhew; Eric | Liposomal hydrolysis-promoting hydrophobic taxane derivatives |
FR2740451B1 (fr) * | 1995-10-27 | 1998-01-16 | Seripharm | Nouveaux intermediaires pour l'hemisynthese de taxanes, leurs procedes de preparation et leur utilisation dans la synthese generale des taxanes |
FR2742751B1 (fr) * | 1995-12-22 | 1998-01-30 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
US7288665B1 (en) * | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
ATE234800T1 (de) | 1997-08-21 | 2003-04-15 | Univ Florida State | Verfahren zur synthese von taxanen |
US5917062A (en) * | 1997-11-21 | 1999-06-29 | Indena S.P.A | Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
EP1068192B1 (en) * | 1998-01-14 | 2002-06-12 | Bristol-Myers Squibb Company | Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol |
CN100348589C (zh) | 1998-05-01 | 2007-11-14 | 梅思医药(美国)股份有限公司 | 从c-7,c-10双苄酯基浆果赤霉素iii合成红豆杉醇的方法和有用的中间体 |
CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
IT1319168B1 (it) * | 2000-03-17 | 2003-09-26 | Indena Spa | Derivati di condensazione ad attivita' antitumorale, loro metodo dipreparazione e formulazioni che li contengono. |
CA2647107A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Anti-tumor cell antigen antibody therapeutics |
DE102008013929B3 (de) * | 2008-03-12 | 2009-04-09 | Wieland-Werke Ag | Verdampferrohr mit optimierten Hinterschneidungen am Nutengrund |
CN101531645B (zh) * | 2009-04-29 | 2012-08-22 | 深圳万乐药业有限公司 | 一种多西他赛的合成方法 |
BR112014031421A2 (pt) | 2012-06-15 | 2017-06-27 | Brigham & Womens Hospital Inc | composições para tratamento de câncer e métodos para produção das mesmas |
AU2015241198A1 (en) | 2014-04-03 | 2016-11-17 | Invictus Oncology Pvt. Ltd. | Supramolecular combinatorial therapeutics |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2629819B1 (fr) * | 1988-04-06 | 1990-11-16 | Rhone Poulenc Sante | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii |
FR2629818B1 (fr) * | 1988-04-06 | 1990-11-16 | Centre Nat Rech Scient | Procede de preparation du taxol |
-
1991
- 1991-07-10 FR FR9108673A patent/FR2678930B1/fr not_active Expired - Fee Related
-
1992
- 1992-07-08 KR KR1019940700046A patent/KR100206458B1/ko not_active IP Right Cessation
- 1992-07-08 CA CA002111319A patent/CA2111319C/fr not_active Expired - Lifetime
- 1992-07-08 PL PL92302030A patent/PL169780B1/pl unknown
- 1992-07-08 SK SK17-94A patent/SK281560B6/sk not_active IP Right Cessation
- 1992-07-08 DK DK92915477.1T patent/DK0593641T3/da active
- 1992-07-08 ES ES92915477T patent/ES2081120T3/es not_active Expired - Lifetime
- 1992-07-08 EP EP92915477A patent/EP0593641B1/fr not_active Expired - Lifetime
- 1992-07-08 HU HU9400062A patent/HU217115B/hu unknown
- 1992-07-08 AU AU23280/92A patent/AU662346B2/en not_active Expired
- 1992-07-08 DE DE69207194T patent/DE69207194T2/de not_active Expired - Lifetime
- 1992-07-08 CZ CZ9431A patent/CZ281288B6/cs not_active IP Right Cessation
- 1992-07-08 WO PCT/FR1992/000649 patent/WO1993001179A1/fr active IP Right Grant
- 1992-07-08 EP EP92401958A patent/EP0522958A1/fr active Pending
- 1992-07-08 AT AT92915477T patent/ATE132145T1/de active
- 1992-07-08 RU RU9294016161A patent/RU2088578C1/ru active
- 1992-07-08 ZA ZA925098A patent/ZA925098B/xx unknown
- 1992-07-08 JP JP05502037A patent/JP3085710B2/ja not_active Expired - Lifetime
- 1992-07-09 IE IE922234A patent/IE73637B1/en not_active IP Right Cessation
- 1992-07-09 MX MX9204029A patent/MX9204029A/es unknown
- 1992-07-09 NZ NZ243491A patent/NZ243491A/en not_active IP Right Cessation
- 1992-07-10 YU YU68792A patent/YU49175B/sh unknown
-
1993
- 1993-12-08 NO NO934485A patent/NO302521B1/no not_active IP Right Cessation
- 1993-12-08 NO NO934485D patent/NO934485D0/no unknown
-
1994
- 1994-01-07 FI FI940075A patent/FI109792B/fi not_active IP Right Cessation
-
1995
- 1995-07-06 US US08/498,613 patent/US5578739A/en not_active Expired - Lifetime
- 1995-12-28 GR GR950402328T patent/GR3018543T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003201287A (ja) * | 1993-03-22 | 2003-07-18 | Aventis Pharma Sa | タキソテレ三水和物 |
JP4367829B2 (ja) * | 1993-03-22 | 2009-11-18 | アベンテイス・フアルマ・ソシエテ・アノニム | タキソテレ三水和物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06509082A (ja) | バッカチン3および10−デアセチルバッカチン3の誘導体類の製造方法 | |
CA2077598C (en) | Alkoxy substituted taxanes and pharmaceutical compositions containing them | |
CA1308417C (fr) | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii | |
DE69809959T2 (de) | Neue taxanderivate | |
CA2214051C (en) | Beta-lactams useful in preparation of taxols | |
CN1130356C (zh) | 具有抗肿瘤活性的半合成断紫杉烷 | |
JPS6330479A (ja) | タキソ−ル誘導体類、それらの製造およびそれらを含有する製薬学的組成物 | |
FR2601676A1 (fr) | Procede de preparation du taxol et du desacetyl-10 taxol | |
FR2629818A1 (fr) | Procede de preparation du taxol | |
SK282162B6 (sk) | Spôsob prípravy derivátov taxánu, deriváty taxánu, deriváty oxazolínu ako medziprodukty na prípravu derivátov taxánu a spôsob ich prípravy | |
DE69608548T2 (de) | 10- deacetylbaccatin iii und 10- deacetyl 14 beta hydroxybaccatin iii derivaten, verfahren zu deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen | |
DE60001265T2 (de) | Verfahren zu herstellung von taxanen aus 10-desacetylbaccatin iii | |
TWI269792B (en) | Process for the preparation of a paclitaxel C-4 methyl carbonate analog | |
JP4068663B2 (ja) | バッカチン誘導体の選択的保護のための方法及びタキサン合成へのその適用 | |
DE69503213T2 (de) | Baccatin-Derivate und Verfahren zu deren Herstellung | |
RU2109010C1 (ru) | ПРОИЗВОДНОЕ β -ФЕНИЛИЗОСЕРИНА, СПОСОБ ЕГО СТЕРЕОСЕЛЕКТИВНОГО ПОЛУЧЕНИЯ, ИСХОДНОЕ СОЕДИНЕНИЕ ДЛЯ ЕГО ПОЛУЧЕНИЯ, СПОСОБ ПОЛУЧЕНИЯ ТАКСАНА И ПРОМЕЖУТОЧНЫЕ ПРОДУКТЫ | |
JP4493755B2 (ja) | バッカチン誘導体の製造方法 | |
EP0747372A1 (en) | Taxane derivatives from 14-beta-hydroxy-10 deacetybaccatin III | |
JPH08295682A (ja) | バッカチン誘導体及びその製法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070707 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080707 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080707 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090707 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090707 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100707 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110707 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110707 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120707 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120707 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130707 Year of fee payment: 13 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130707 Year of fee payment: 13 |